Bio Longevity Labs - About the company
Bio Longevity Labs is an unfunded company based in Austin (United States), founded in 2024. It operates as a Manufacturer of research peptides and bioregulators. Bio Longevity Labs has not raised any funding yet. The company has 67 active competitors, including 7 funded and 10 that have exited. Its top competitors include companies like AmbioPharm, Enzene and PolyPeptide.
Company Details
Manufacturer of research peptides and bioregulators. It produces peptides and bioregulators for research and development purposes. The manufacturing process adheres to Good Manufacturing Practices (GMP), utilizing advanced techniques for synthesis, cleavage, and purification. Third-party testing ensures purity and safety. Products are sold directly to researchers and health professionals.
Key Metrics
Founded Year
2024
Location
Austin, United States
Stage
Unfunded
Ranked
54th among 67 active competitors
Similar Companies
Sign up to download Bio Longevity Labs' company profile
Bio Longevity Labs's funding and investors
Bio Longevity Labs has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Bio Longevity Labs's Competitors and alternates
Top competitors of Bio Longevity Labs include AmbioPharm, Enzene and PolyPeptide. Here is the list of Top 10 competitors of Bio Longevity Labs, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AmbioPharm 2006, North Augusta (United States), Acquired | Peptide manufacturing and development services, setting a new standard worldwide | $24M | 58/100 | |
2nd | Company specializing in development of Biosimilars | $50M | 55/100 | ||
3rd | PolyPeptide 1952, Baar (Switzerland), Public | CMO manufacturing proprietary,GMP grade and non-GMP-grade peptides | - | - | 48/100 |
4th | Shaanxi Micot Technology 2007, China, Series B | Provider of drug research and development services focused on cardiovascular and metabolic diseases | $72.2M | 45/100 | |
5th | Hybio Pharmaceutical 1998, Shenzhen (China), Public | Developer and manufacturer of polypeptide drugs and APis | $15M | 43/100 | |
6th | JPT Peptide 2004, Berlin (Germany), Acquired | Peptide based CRO offering proteomics, biomarker and drug discovery services | - | - | 41/100 |
7th | Custom Peptide Synthesis 2011, Mumbai (India), Unfunded | Manufacturer of peptides and other finished formulations, & APIs | - | - | 40/100 |
8th | Proteos Biotech 2010, Madrid (Spain), Unfunded | Manufacturer of recombinant enzymes and provides CMO services | - | - | 38/100 |
9th | Developer and manufacturer of generic pharmaceuticals, nutraceuticals, food supplements and veterinary products | - | 37/100 | ||
10th | USV Peptides 2011, Mumbai (India), Unfunded | CDMO offering custom peptide, GMP peptide and cosmetic peptide synthesis services | - | - | 34/100 |
54th | ![]() Bio Longevity Labs 2024, Austin (United States), Unfunded | Manufacturer of research peptides and bioregulators | - | - | 16/100 |
Looking for more details on Bio Longevity Labs's competitors? Click here to see the top ones
Bio Longevity Labs's Investments and acquisitions
Bio Longevity Labs has made no investments or acquisitions yet.
Reports related to Bio Longevity Labs
Here is the latest report on Bio Longevity Labs's geography:
News related to Bio Longevity Labs
•
BioLongevity Labs Wants To Demystify Peptides For The MassesIndie Beauty Media Group LLC•Jan 10, 2025•Bio Longevity Labs
Are you a Founder ?
FAQs about Bio Longevity Labs
Explore our recently published companies
- Gravityinternet - Unfunded company
- Linuxfi - Unfunded company
- Celticcross - Unfunded company
- Enggtree - Unfunded company
- Kflap - Unfunded company
- Tong Garden - Singapore based, 1980 founded, Unfunded company
